STOCK TITAN

Masimo Corporation - MASI STOCK NEWS

Welcome to our dedicated page for Masimo Corporation news (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo Corporation stock.

Masimo Corporation (NASDAQ: MASI) is a leading global medical technology company specializing in the development and manufacturing of innovative noninvasive patient monitoring technologies. For over 27 years, Masimo has been at the forefront of medical advancements, offering a wide array of sensors and devices that enhance patient care and safety. Their products are designed to provide healthcare professionals with critical information to improve clinical decision-making.

Masimo's core business is divided into two segments: healthcare and non-healthcare. The healthcare segment is the primary revenue generator, focusing on noninvasive patient monitoring technologies, hospital automation, connectivity solutions, and remote monitoring devices. Their clinically proven products are widely used in hospitals, emergency rooms, and clinical settings around the world.

The non-healthcare segment encompasses the consumer audio business, which includes the development, manufacturing, marketing, and licensing of premium and luxury audio sound products. This segment is known for its advanced audio integration technologies that appeal to audiophiles and general consumers alike.

Masimo's recent achievements include expanding their product portfolio with advanced remote monitoring solutions, partnering with leading healthcare organizations, and pioneering innovative technologies that address unsolvable medical challenges. Financially, the company is robust, showing consistent growth and a strong market presence.

Masimo’s dedication to improving lives is evident in their mission to save, extend, and enhance the quality of life across all demographics. Their innovative spirit attracts individuals who are passionate about making a significant impact in the medical field. As they continue to innovate, Masimo remains committed to providing top-tier products that meet the evolving needs of the healthcare industry.

Rhea-AI Summary
Masimo to participate in Wells Fargo Healthcare Conference on September 8, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
conferences
-
Rhea-AI Summary
Leading Louisiana and Mississippi Healthcare Provider Standardizes 10 Hospitals on Masimo SET® and Patient SafetyNet™ to Enhance Patient Safety and Improve Patient Outcomes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
Rhea-AI Summary
Masimo announces full U.S. market release of Stork smart home baby monitoring system
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
none
Rhea-AI Summary
Masimo's noninvasive, continuous PVi reduces cardiopulmonary complications and fluid administered during GI surgery on elderly patients, according to a study. PVi group had significantly lower rate of cardiopulmonary complications (8.4% vs 19.2%) and lower total volume of fluid administered (median 2075 ml vs. 2500 ml).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
-
Rhea-AI Summary
Masimo Corporation (Nasdaq: MASI) announced its financial results for the second quarter of 2023. Consolidated revenue was $455.3 million, with healthcare revenue at $281.1 million and non-healthcare revenue at $174.2 million. GAAP net income per diluted share was $0.29, while non-GAAP net income per diluted share was $0.62. Despite a decline in healthcare revenues and earnings, Masimo gained new hospital customers at a record level and retained existing ones. The updated guidance reflects lower inpatient volumes and the expectation of not receiving some new large orders for their products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.7%
Tags
-
Rhea-AI Summary
Masimo (NASDAQ: MASI) announced that a study found Masimo SedLine® brain function monitoring effectively assesses sedation levels of patients undergoing drug-induced sleep endoscopy with dexmedetomidine, indicating potential to improve monitoring of dexmedetomidine sedation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none
-
Rhea-AI Summary
Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1 advanced health tracking watch. The watch offers accurate, continuous measurements of key physiological parameters and integrates with the Masimo SafetyNet remote patient management and telehealth platform. The hospital plans to equip patients scheduled for elective surgery with the watch to improve prehabilitation through analysis of heart rate variability data.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.59%
Tags
none

FAQ

What is the current stock price of Masimo Corporation (MASI)?

The current stock price of Masimo Corporation (MASI) is $169.52 as of December 20, 2024.

What is the market cap of Masimo Corporation (MASI)?

The market cap of Masimo Corporation (MASI) is approximately 9.1B.

What is Masimo Corporation's main business?

Masimo Corporation specializes in developing and manufacturing noninvasive patient monitoring technologies and premium audio products.

How long has Masimo Corporation been in operation?

Masimo has been operational for over 27 years, continually innovating in the medical technology field.

What are the key segments of Masimo's business?

Masimo operates in two key segments: healthcare, which includes patient monitoring technologies, and non-healthcare, which includes premium audio products.

What products does Masimo offer?

Masimo offers noninvasive patient monitoring devices, sensors, remote monitoring solutions, hospital automation products, and luxury audio sound systems.

What makes Masimo's products unique?

Masimo's products are known for their innovative, noninvasive technology that provides accurate patient monitoring and critical information for clinical decision-making.

Who uses Masimo's healthcare products?

Masimo's healthcare products are used by healthcare professionals in hospitals, clinics, emergency rooms, and other medical settings.

What recent achievements has Masimo Corporation accomplished?

Masimo has expanded their product portfolio with advanced remote monitoring solutions and established partnerships with leading healthcare organizations.

What is the financial status of Masimo Corporation?

Masimo Corporation has shown consistent financial growth and maintains a strong market presence.

What is Masimo's mission?

Masimo's mission is to save, extend, and improve lives by developing innovative medical technologies and solutions.

Where can I find the latest news about Masimo Corporation?

The latest news about Masimo Corporation can be found on their official website and trusted financial news sources.

Masimo Corporation

Nasdaq:MASI

MASI Rankings

MASI Stock Data

9.12B
49.16M
8.19%
94.77%
6.24%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
IRVINE